TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
FrostPharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
16,493
|
12,523
|
7,745 |
Financial expenses |
267
|
190
|
187 |
Earnings before taxes |
1,262
|
2,544
|
-545 |
EBITDA |
1,649
|
2,795
|
-356 |
Total assets |
11,463
|
9,007
|
5,957 |
Current assets |
10,746
|
8,263
|
5,707 |
Current liabilities |
3,941
|
6,086
|
5,309 |
Equity capital |
3,799
|
2,808
|
648 |
- share capital |
5
![]() |
5
|
6 |
Employees (average) |
15
|
10
|
8 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
33.1%
|
31.2%
|
10.9% |
Turnover per employee |
1,100
|
1,252
|
968 |
Profit as a percentage of turnover |
7.7%
|
20.3%
|
-7.0% |
Return on assets (ROA) |
13.3%
|
30.4%
|
-6.0% |
Current ratio |
272.7%
|
135.8%
|
107.5% |
Return on equity (ROE) |
33.2%
|
90.6%
|
-84.1% |
Change turnover |
3,933
|
5,406
|
-8,213 |
Change turnover % |
31%
|
76%
|
-51% |
Chg. No. of employees |
5
|
2
|
3 |
Chg. No. of employees % |
50%
|
25%
|
60% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.